ABSTRACT
Aims: COVID-19 has been a big public health challenge around the world in the past several months. The aim of this study is to describe the epidemic and report the number of confirmed cases of COVID-19 in Mexico until March 23, 2020.Study Design:Ecological descriptive study.Place and Duration of Study:Registries of confirmed cases for COVID-19 in Mexican population during February and until 23 March 2020, from National System of Epidemiological Surveillance/ General Direction of Epidemiology/ Secretary of Health, Mexico. Methodology:Based on the database of confirmed cases of COVID-19 by Secretary of Health in Mexico, we collected data on age, gender, and source of infection (travel to USA, European or Asian countries. As of March 23, 2020, 405 cases have been identified in Mexico. It was included 405 registries. Results:The first confirmed case in Mexico has been identified on February 20, 2020 and the incidence has been rising from the end of February and throughout March. The early confirmed cases were imported cases resulting from travel to USA, Italy, Germany, Spain, France and Singapore. No one travelled to China. No cases of community transmission have been reported.Conclusion:The frequency of confirmed cases of COVID-19 in Mexico are concerning and the health authorities in Mexico are waiting for the peak of the epidemiological curve to occur in April
ABSTRACT
Aims:Disease for a novel coronavirus has been a big public health challenge around the world in the past several months. The aim of this study is to describe the epidemic and report the number of confirmed cases and deaths of disease for a novel coronavirus inMexico until May 15, 2020.Study Design:Ecological study.Place and Duration of Study: Registries of confirmed cases for disease for a novel coronavirus in Mexican population during January and until May 15, 2020, from National System of EpidemiologicalSurveillance/ General Direction of Epidemiology/ Secretary of Health, Mexico.Methodology: Based on the database of confirmed cases of disease for a novel coronavirus by Secretary of Health in Mexico, we collected data on age, gender, and deaths, and co-morbidities. As of May 15, 2020, 45,032 cases have been identified in Mexico. Results: The first confirmed case in Mexico has been identified on January 8, 2020 and the incidence has been rising from the end of February and throughout March. The early confirmed cases were imported cases resulting from travel to USA, Italy, Germany, Spain, France and Singapore. No one travelled to China. No cases of community transmission have been reported. The cause-specific mortality rate was 10.59% and the possibility to death is three times more if comorbidities are in the patient.Conclusion:The frequency of confirmed cases of disease for a novel coronavirus in Mexico are concerning and the health authorities in Mexico are waiting for the peak of the epidemiological curve to occur in May. The mortality is high with co-morbidities
ABSTRACT
Aims: Identify the correlation between systolic and diastolic blood pressure measurement with digital arm and wrist baumanometers in young adults aged 18 to 40 at the Public University of Celaya, Guanajuato, Mexico. Study Design: Observational, analytical, quantitative, correlational, diagnostics.Place of Study: Public University of Celaya, Guanajuato, Mexico.Methodology: We included 397 participants of an age range between 18 and 40 years; which 287 were women and 110 were men; with an average weight of 65.28 ± 15.08, and of stature 1.63 ± 0.09. Two types of digital, wrist and arm baumanometers were used to measure the systolic and diastolic blood pressure to observe the effectiveness of the valuesrecorded during the measurement.Results: The correlation between the 3 measurements of the systolic blood pressure was repeated in the first and third measurements (r = 0.46) and varied in the second (r = 0.39), in all three the value recorded by the highest arm baumanometer was found. In the 3 measurements of the diastolic blood pressure the correlation varied (r = 0.54, r = 0.50, r = 0.59); registering the highest value in the measurement with the arm baumanometer.Conclusion: The correlation between the measurements with the baumanometers was not perfect, however it was good, it was considered that the measurement of blood pressure with the wrist baumanometer should be done with the wrist at the level of the heart; as well as movements of arm, hand or fingers will alter the result
ABSTRACT
Aims: To identify if there is a correlation between lycopene intake and blood pressure levels in healthy adults of Celaya.Study Design:Cross-sectional, observational, analytical study.Place:All students registered at a public university in Celaya, Guanajuato, Mexico Methodology:To measure blood pressure, a humeral digital baumanometer with adult bracelet (Rossmax MG150f) was used. The measurement was performed three times with a two-minuteinterval and the average systolic and diastolic blood pressure was obtained. The daily intake of lycopene was evaluated with a questionnaire of the frequency of consumption of meals. Theμg of lycopene were estimated with software related to the frequencyof consumption of meals. Descriptive statistics were used for all variables.To identify the correlation and possible linear relationship between lycopene intake and blood pressure, Pearson r was calculated, linear regression equation, t-test, and P-valueand Confidence Intervals at 95%.Results: We included 446 participants (74.28% women, 25.78% men; between 18-51 years of age). The average systolic blood pressure was108.30 mmHg, while the average diastolic blood pressure was 71.07 mmHg. The mean daily intake of lycopene was 6477.38 μg. However, there was no correlation or lineal relationship between lycopene intake and the measurement of systolic blood pressure (P=.93) and diastolic blood pressure (P=.5). Conclusion: No correlation was found between daily intake of lycopene and blood pressure (P> .05) in this adult sample from Celaya, Mexico. Studies should be conducted with a different way of determining the intake or level of lycopene in the body